SBI Securities’s Solid Biosciences SLDB Stock Holding History

SBI Securities’s Portfolio SLDB Stock Details SLDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$6.13K	Sell	848 -9	-1%	-$81	﹤0.01%	2101
2026 Q2	$8.56K	Sell	857 -20	-2%	-$152	﹤0.01%	1917
2026 Q1	$6.31K	Buy	877 +121	+16%	+$777	﹤0.01%	1932
2025 Q4	$4.26K	Sell	756 -8	-1%	-$43	﹤0.01%	2085
2025 Q3	$4.71K	Buy	764 +355	+87%	+$2.08K	﹤0.01%	2071
2025 Q2	$1.99K	Sell	409 -132	-24%	-$467	﹤0.01%	2381
2025 Q1	$2K	Buy	541 +263	+95%	+$1.13K	﹤0.01%	2290
2024 Q4	$1.11K	Buy	+278	New	+$1.53K	﹤0.01%	2557

Other funds holding SLDB

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Quantum Private Wealth Tampa, Florida $391M AUM 50.76% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

SBI Securities's SLDB Position: Q3 2026 in Review

SBI Securities reduced its Solid Biosciences (SLDB) stake by 1.1% in Q3 2026, selling an estimated $81 and leaving 848 shares worth $6.13K. The position accounts for ﹤0.01% of the portfolio, ranked #2101.

SBI Securities first reported a position in SLDB in Q4 2024 and has held it in 8 quarters since. The position peaked at $8.56K in Q2 2026. 15 funds tracked by Wall St. Rank hold SLDB as of Q3 2026.

SBI Securities held 848 shares of Solid Biosciences worth $6.13K as of Q3 2026.
SBI Securities sold 9 Solid Biosciences shares in Q3 2026, an estimated $81.
Solid Biosciences made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #2101 holding.
SBI Securities first reported a position in Solid Biosciences in Q4 2024 and has held it in 8 quarters since.
SBI Securities's Solid Biosciences position peaked at $8.56K in Q2 2026.
15 funds tracked by Wall St. Rank held Solid Biosciences as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.